Cabozantinib is a targeted therapy drug widely used in the treatment of various cancers such as kidney cancer, liver cancer, and thyroid cancer.
The Lucius version of Cabozantinib has a drug specification of 20 mg * 90 tablets and a price of approximately $138. In addition to the Lucius version, there are multiple other versions of Cabozantinib generic drugs available on the market for selection. When patients choose drugs, in addition to considering price factors, they should also conduct a comprehensive evaluation based on their own condition, doctor's advice, and the quality of the drugs.
Cabozantinib is an important anti-tumor drug, and its price has always been the ···【more】
Release date:2025-02-12Recommended:118
Cabozantinib is an important targeted therapy drug, and its price dynamics have ···【more】
Release date:2025-02-12Recommended:111
As a multi-targeted tyrosine kinase inhibitor, cabozantinib has shown broad appl···【more】
Release date:2025-02-11Recommended:119
Cabobrutinib is a tyrosine kinase inhibitor that primarily targets MET, VEGFR an···【more】
Release date:2024-11-14Recommended:152